ThePeptide.expert
This information is for research and educational purposes only. This is not medical advice.
← All profiles
Cat 1 — 2026LongevityRecoverySkin & hair

GHK-Cu

Copper peptide / Glycyl-L-histidyl-L-lysine-Cu²⁺

Naturally occurring copper-binding peptide found in human plasma. Declines significantly with age. Influences over 4,000 genes. Strongest evidence base for topical skin applications.

Evidence
Strong clinical data
Routes
injectable, topical
Available since
Discovered 1973 (Pickart). Skincare use since 1990s. Injectable research use from approximately 2010s onward.

Mechanism of action

Transports copper ions essential for collagen synthesis. Activates over 30 tissue repair genes while suppressing inflammation genes. Acts as antioxidant, stimulates collagen and elastin production, activates stem cells. Gene expression effects documented across 4,000+ genes.

Effects in the body

GHK-Cu is naturally present in your body and naturally declines with age — from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. It activates broad genetic repair programming. Best human evidence comes from topical wound healing and skin research.

Pros & cons (from the literature)

Pros
  • Naturally occurring compound — exceptional tolerability profile
  • 4000+ gene expression effects documented in research
  • Strong topical wound healing and skin repair evidence
  • Anti-inflammatory, antioxidant, and anti-fibrotic properties
  • Hair growth stimulation data in topical studies
Cautions
  • Injectable systemic data much thinner than topical evidence base
  • Injectable dosing in humans not well characterized
  • Copper toxicity theoretical at very high injectable doses
  • Most robust human evidence comes from cosmetic topical use
  • Systemic effects of injectable form largely unexplored

Protocol summary (from published research)

Topical: 0.1–3% concentration in serums or creams, applied twice daily — well-established and widely used. Injectable (research): 0.5–1 mg subcutaneous 2–3 times weekly near target tissue — protocols vary significantly and are exploratory.

Dosing ranges reproduced from published research literature. Not a prescription, not medical advice.

FDA & regulatory status

Category 1 specifically for topical use as of February 2026. Injectable GHK-Cu remains off the approved compounding list. Widely sold and used as a cosmetic ingredient in topical serums and creams.

Evidence base

Strong topical wound healing RCT data exists. Loren Pickart published extensively on mechanisms. Injectable human clinical data remains exploratory as of 2026.

Primary research sources

Peer-reviewed literature referenced throughout this profile is drawn from PubMed, Cell Metabolism, and clinical trial registries cited in the evidence base above.

Expert perspective — Dr. Alex Tatem, Urologist

Dr. Alex Tatem is a board-certified Urologist and Men's Health Specialist who has studied peptides for 12 years. Videos featured for educational purposes. ThePeptide.expert is an independent platform.

Dr. Tatem covers GHK-Cu as a topical copper peptide that boosts collagen and elastin — one of the most accessible peptides for skin research.

Pro member exclusive

Significant savings on research-grade peptides at a licensed, quality-controlled supplier

Your Pro membership includes an exclusive discount code for 99%+ purity verified research peptides at the best available price, from a licensed supplier we have evaluated for purity standards and compliance. Plus curated guides so you know exactly what to research.

  • • Exclusive discount code included with Pro membership
  • • Curated guide for this specific peptide
  • • Verified 99%+ purity compounds
  • • Removes the guesswork entirely
Upgrade to Pro — $15/month

Cancel anytime · No long-term commitment

Important. ThePeptide.expert summarizes published research. We are not a pharmacy, do not prescribe, and make no therapeutic claims. Regulatory status varies by jurisdiction.